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ABSTRACT: The four-step procedure involving bromination, reduction, and
nucleophilic substitution via elimination/addition previously applied to 1-(2-
pyridyl)-2-propen-1-ol for the synthesis of indolizidine systems has now been
extended to 1-(2-quinolyl)-2-propen-1-ol allowing a general access to benzo-fused
derivatives. For instance, (±)-benzo[e]lentiginosine has been easily synthesized in an
18% overall yield.
■ INTRODUCTION
In 1988, Evans introduced the term “privileged structures” to
define molecular frameworks “capable of providing useful
ligands for more than one receptor,” which upon modifications
“could be a valuable alternative in the search for new receptor
agonists and antagonists.”1 The principle of privileged
structures has been widely applied for the design and synthesis
of libraries of natural products and their analogues by planning
diversity-oriented syntheses2 to access molecules (often small
molecules) with maximum structural diversity.
Heterocyclic systems and mainly six-membered aza-hetero-
cycles, including pyridines,3 quinolines,4 and their reduced
forms such as 1,2,3,4-tetrahydroquinolines,5 are privileged
structures because they are widely spread in nature and are
well-known for their multifaceted biological activities as well as
for their significant applications in the pharmaceutical and
agrochemical domains.
Moreover, indolizidine alkaloids, and mainly polyhydroxy-
lated derivatives, have been recognized as potent and selective
inhibitors of glycosidases and have also been investigated as
antibacterial, antiviral, antitumor, antiinflammatory, or anti-
diabetic agents.6 In particular, from its isolation in 1990, a
noteworthy attention has been devoted to natural (+)-lentigi-
nosine [(1S,2S,8aS)-octahydroindolizine-1,2-diol]7 as well as to
the non-natural enantiomer able to behave, respectively, as
amyloglucosidase and Hsp90 inhibitor or apoptosis inducer on
tumor cells of different lines.8
In this context, we recently reported a facile four-step
synthesis of rac-lentiginosine from 1-(2-pyridyl)-2-propen-1-
ol.9 With the aim to synthesize different analogues to test their
biological properties, we then decided to apply the same
methodology to 1-(2-quinolyl)-2-propen-1-ol (1)10 to access
benzo[e]indolizidines with a tetrahydroquinoline skeleton
(Figure 1), assessed as promising targets on the basis of
computational studies.11
■ RESULTS AND DISCUSSION
1-(2-Quinolyl)-2-propen-1-ol (1) was synthesized in 94% yield
from 2-quinolinecarboxaldehyde, but the easy isomerization
into the corresponding ethyl ketone10 made its purification
impossible. After isolation, compound 1 was immediately
subjected to bromination with a stoichiometric amount of
bromine in dichloromethane at 0 °C, affording a mixture of
diastereomeric trans and cis benzoindolizinium salts 2 and 3
(1:2−1:3 ratio), recovered in 97% yield by ensuing multiple
filtrations (Scheme 1). The diastereomeric salts cannot be
separated but simple stirring in water at room temperature
allowed the total conversion of the cis isomer into trans-salt 2,
which was then isolated in a quantitative yield (Scheme 1). As
previously observed for indolizinium salts,9 in polar solvents,
the solvent-separated ion pairs in 2 and 3 are likely able to
evolve into the more stable trans isomer 2 through the
nucleophilic attack of the bromide ion on C-2 carbon.a
Salt 2 was then subjected to reduction under different
conditions. The use of NaBH4 led to complex reaction
mixtures, whereas no reduction was observed for hydrogenation
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Figure 1. General approach to benzo[e]indolizidines from 1-(2-
quinolyl)-2-propen-1-ol (1).
Scheme 1. Bromocyclization of 1-(2-Quinolyl)-2-propen-1-
ol (1) and Cis/Trans Salt Isomerization
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in the presence of Pd/C. On the other hand, hydrogenation in
the presence of monohydrate PtO2 as the catalyst afforded the
formation of diastereomeric tetrahydroquinolines bromohy-
drates 4 and 5 (Scheme 2).b Compounds 4 and 5 are
completely stable as hydrobromides, but attempts to isolate the
bromohydrins as free bases were unsuccessful.c
The mixture of 4 and 5 was then subjected to treatment with
aqueous KOH in tetrahydrofuran (THF) affording diastereo-
meric epoxides 6 and 7 isolated in 23 and 16% yields,
respectively, by column chromatography (Scheme 2). It is
worthy to note that epoxides 6 and 7 are the first products
purified after four reaction steps, then involving an averaged
80% yield for any single step.
The trans-OH/Br relationship in 4 and 5 is certainly
responsible for intramolecular SN2 reactions leading to oxiranes
6 and 7, respectively, via formal HBr elimination (Figure 2).
With oxiranes 6 and 7 in hand, ring opening reactions with
different nucleophiles were studied.
When oxirane 6 was treated with aqueous H2SO4 in THF at
100 °C in a screw-cap tube (see Experimental Section) for 24 h,
a 3:1 mixture of diols 8 and 9 was recovered in 35% yield
(Table 1, entry 1).
The formation of the reaction products can be rationalized
trough a totally anti diastereoselective and highly C-2
regioselective nucleophilic attack of water on epoxide 6
(activated by protonation at oxygen and/or nitrogen) (Scheme
3).
The separation of diols was however unsuccessful. The same
reaction was then performed with D2O as the solvent under
different conditions to evaluate the selectivity of the process via
1H NMR analyses. The formation of diol 8 indeed improved at
60 °C, but the reaction times were too long (Table 1, entry 2),
whereas operating at 80 or 100 °C, the transformation was
faster, but the selectivity decreased (Table 1, entries 3 and 4).
An analogous study was undertaken on oxirane 7. Operating
in THF at 100 °C, diols 8 and 9 were isolated in 64% yield as a
1:4 mixture (Scheme 3, Table 1, entry 5). 1H NMR analyses of
reactions performed in D2O showed a higher reactivity for 7,
compared to 6, that underwent a total conversion even at 40 or
60 °C (Table 1, entries 6 and 7). Operating in water at 40 °C, a
1:3.5 mixture of diols was recovered in 72% yield (Table 1,
entry 8).d
Reactions of oxiranes 6 and 7 in dry MeOH, in the presence
of conc. H2SO4 allowed to recover the methoxy derivatives 10−
13 in 70 and 11% yields and 67 and 9% yields, respectively
(Scheme 4). In this case, the selectivity is higher and the major
isomer derives again from a totally anti diastereoselective and
highly C-2 regioselective nucleophilic attack of methanol on
activated epoxides 6 and 7. Small amounts of diols 8 and 9 were
also recovered (see Experimental Section).
Oxirane ring opening was then studied with acetic acid as the
solvent. When heated at 60 °C for 3 days, compound 6 afforded
only traces of monoacetates, whereas total decomposition of
the starting material was observed for compound 6 after 48 and
24 h at 80 and 100 °C, respectively, and even for epoxide 7
when heated at 60 °C for 4 days.
Scheme 2. Synthesis of Oxiranes 6 and 7 by Reduction of Trans Salt 2 and HBr Elimination
Figure 2. Intramolecular SN2 reactions on bromohydrins 4 and 5.
Table 1. Nucleophilic Attack of Water on Oxiranes 6 and 7
entry oxirane solvent T (°C) time
conversiona
(%)
8:9
ratioa
yieldb
(%)
1 6 THF 100 24 h 100 3:1 35
2 6 D2O 60 15 d 100 7:1
3 6 D2O 80 72 h 100 3.5:1
4 6 D2O 100 24 h 100 2.5:1
5 7 THF 100 24 h 100 1:4 64
6 7 D2O 40 24 h 100 1:4
7 7 D2O 60 24 h 100 1:4
8 7 H2O 40 60 h 100 1:3.5 72
aDetermined via proton nuclear magnetic resonance (1H NMR)
spectroscopy. bIsolated yields.
Scheme 3. Formation of Diols 8 and 9 from Oxiranes 6 and 7
Scheme 4. Formation of Methoxy Derivatives 10−13 from
Oxiranes 6 and 7
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Accidentally, a different pathway was observed operating in
AcOH in the presence of concentrated H2SO4.
e Heating
compound 6 for 7 h in glacial AcOH at 60 °C allowed to isolate
diacetate 15 in 60% yield along with minor amounts of
regioisomeric monoacetates 14a,b (1:1 ratio, 14%) and diol 8
(8%) (Scheme 5).
By contrast, epoxide 7, under the same conditions for 36 h,
gave a complex reaction mixture of isomeric monoacetates,
diacetates, and diols (1H NMR). Careful chromatographic
separation allowed to recover a 1:3.5 mixture of diacetates 15
and 17 in 30% yield along with monoacetates 14a,b and 16a,b
(1:5 ratio, 28%) and diols 8 and 9 (1:2 ratio, 8%) (Scheme 5).
It is worth to note that in the case of oxirane 6, all reaction
products show the same relative stereochemistry on the three
stereogenic centers as the fruit of totally anti diastereoselective
and totally C-2 regioselective nucleophilic attacks on the
epoxide ring. This result can be rationalized considering
different nucleophilic attacks on suitably activated intermediates
(Scheme 6).
Anti diastereoselective attack of AcOH on the C-2 carbon of
protonated oxirane 6a affords monoacetate 14a, easily
converted into diacetate 15 by esterification. Compound 15
can also arise from acetylated epoxide 6b via nucleophilic attack
of AcOH at position 2, whereas nucleophilic attack of H2O can
give monoacetate 14b. Hydrolysis of all reaction products can
produce diol 8.
The same mechanism can justify the results observed for
epoxide 7, invoking totally anti diastereoselective attacks, but in
this case, only preferential regioselective attacks at position 2.
On the basis of these results, running a one-pot reaction for
compound 6, including oxirane ring opening in AcOH/H2SO4,
followed by hydrolysis under the same conditions allowed to
isolate rac-benzo[e]lentiginosine 8 as the sole reaction product
in 82% yield (Scheme 7).
Concerning diol 8, the relative stereochemistry of the
stereogenic centers was unambiguously confirmed by nuclear
Overhauser enhancement spectroscopy (NOESY)-one-dimen-
sional (1D) experiments recorded in CDCl3, evidencing dipolar
couplings for proton H-10a at δ 3.32 with H-2 (pseudo quartet
at 4.37 ppm) and H-3α (doublet-of-doublets at 3.68 ppm)
(Figure 3).
As previously evidenced, oxirane ring openings in acidic
water or MeOH show a higher reactivity for 7 compared to 6,
probably because of a more difficult anti nucleophilic attack in
the latter for the presence of the nitrogen lone pair (see
Scheme 3). On the other hand, compound 6 showed a higher
reactivity (with total regioselectivity) in AcOH after addition of
H2SO4 (complete transformation at 60 °C in 7 h for 6 and in
36 h for 7). This different behavior could be rationalized in
terms of acid−base interactions between AcOH and the ring
nitrogen. This coordination could favor the anti nucleophilic
attack only in oxirane 6 because in compound 7 the nitrogen
lone pair is on the same side with respect to the oxirane bridge
(Figure 4). Likely for 6, the same coordination is also able to
direct the nucleophilic attack of AcOH exclusively at position 2.
■ CONCLUSIONS
In conclusion, these results clearly show the possibility of a
general application of this new methodology exploiting
pyridine-2-carboxaldehyde derivatives as commercially available
starting materials for the synthesis of pyridyl-2-propen-1-ol
systems and conversion into various functionalized indolizi-
dines through a four-step approach involving bromination/
reduction/nucleophilic substitution via elimination/addition. In
Scheme 5. Ring Opening of Oxiranes 6 and 7 with AcOH
and H2SO4
Scheme 6. Ring Opening of Oxirane 6 with AcOH:
Mechanistic Rational
Scheme 7. One-Pot Formation of rac-Benzo[e]lentiginosine
8 from Oxirane 6
Figure 3. Dipolar couplings for compound 8 (from NOESY-1D
experiments).
Figure 4. Ring openings of 6 and 7 in AcOH/H2SO4.
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particular, the use of 2-quinolinecarboxaldehyde allowed the
synthesis of polynuclear tetrahydroquinolines, well-recognized
as privileged structures with many different applications. For
instance, the tricyclic moiety of benzo[e]indolizidine is present
in naturally occurring alkaloids, such as incargranine B isolated
from Incarvillea mairei var. grandiflora, a member of the genus
Incarvillea, from which several derivatives with a strong
antinociceptive activity have been isolated (Figure 5).12
Moreover, synthetic tetracyclic derivatives of type I showed
good in vitro inhibiting activity toward human lung cancer cells,
human hepatoma cells, and acute myeloid leukemia cells
(Figure 5).13
■ EXPERIMENTAL SECTION
General. Melting points were taken on a Stuart Scientific
SIMP3 apparatus and are uncorrected. Silica gel plates (Merck
F254) and silica gel 60 (Merck, 230−400 mesh) were used for
thin-layer chromatography and flash chromatography (FC),
respectively; petroleum ether (PE) employed for chromato-
graphic workup refers to the fraction of bp 40−70 °C. Infrared
(IR) spectra were recorded with a Shimadzu FT-IR 84 00S
spectrophotometer. 1H and 13C NMR spectra were recorded
with Varian Mercuryplus 400 and Varian Inova instruments
operating at 400 and 100 MHz, respectively. Elemental analyses
were performed with a PerkinElmer 2400 analyzer. Accurate
mass spectra were recorded on a LTQ-Orbitrap high-resolution
mass spectrometer (Thermo, San Jose, CA, USA) equipped
with a conventional electrospray ionization (ESI) source.
(2SR,3SR)-2-Bromo-3-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-
a]quinolinium Bromide (2) and (2RS,3SR)-2-Bromo-3-
hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]quinolinium Bromide
(3). In a typical procedure 2-quinolinecarboxaldehyde (1.000 g,
6.36 mmol) was dissolved in dry diethyl ether (80 mL), and 1.0
M solution of vinylmagnesium bromide in THF (8.26 mmol,
8.26 mL) was added at 0 °C.10 After workup, 1-(2-quinolyl)-2-
propen-1-ol (1) (1.108 g, 5.98 mmol, 94% yield) was recovered
as an orange oil that was immediately dissolved in CH2Cl2 (24
mL), and a solution of bromine (0.956 g, 0.306 mL, 5.98
mmol) in the same solvent (12 mL) was added dropwise (ca. 1
h), keeping the reaction vessel at 0 °C under magnetic stirring.
At the end of addition, the reaction mixture was stirred for 30
min at 0 °C and then maintained at room temperature
overnight. An approximately 1:2 mixture (1H NMR) of salts 2
and 3 (1.754 g, 85% with respect to 1) as a dark green solid was
recovered by filtration. 1H NMR (CD3OD):
f δ [9.27 (d, J = 8.8
Hz, 1H)], 9.18 (d, J = 8.7 Hz, 1H), 8.54 (d, J = 8.1 Hz, 1H),
[8.46 (d, J = 7.9 Hz, 1H)], 8.40−8.35 (m, 2H, 2 and 3), [8.31
(m, 1H)], 8.25−8.16 (m, 3H, 2 and 3), [8.08 (m, 1H)], 8.01
(m, 1H), 5.96 (d, J = 2.0 Hz, 1H), [5.87 (d, J = 6.8 Hz, 1H)],
[5.80 (dd, J = 13.1 and 7.7 Hz, 1H)], [5.23 (dd, J = 13.0 and
7.8 Hz, 1H)], 4.96 (ddd, J = 10.2, 5.1 and 2.0 Hz, 1H), [4.81
(m, 1H)], 4.16−4.05 (m, 2H).g 13C NMR (CD3OD): δ [162.1
(s)], 162.0 (s), [149.7 (d)], 148.7 (d), 138.95 (s), [137.8 (s)],
[137.5 (d)], 136.6 (d), [131.6 (d, 2x)], 131.45 (d), [131.0 (s)],
130.6 (d), 129.95 (s), 121.6 (d), 120.85 (d), [119.8 (d, 2x)],
[82.4 (d)], 70.5 (d), [61.5 (t)], 55.6 (d), [46.0 (d)], 32.5 (t).g
Ensuing filtrations allowed to recover a second crop of salts 2
and 3 (0.248 g, 12% with respect to 1).
(2SR,3SR)-2-Bromo-3-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-
a]quinolinium Bromide (2). The mixture of salts 2 and 3
(0.690 g, 2.00 mmol) was dissolved in water (100 mL) and
stirred at room temperature for 3 days, affording compound 2
as a black solid (0.690 g, 100%): mp > 370 °C. IR, νmax (KBr):
3134, 3076, 2990, 2966, 1620, 1596, 1527, 1055, 847, 779
cm−1. 1H NMR (DMSO-d6): δ 9.34 (d, J = 8.5 Hz, 1H), 8.52
(d, J = 7.4 Hz, 1H), 8.44 (d, J = 8.5 Hz, 1H), 8.30 (m, 1H),
8.22 (d, J = 8.6 Hz, 1H), 8.06 (pseudo t, J = 7.6 Hz, 1H), 5.82
(d, J = 7.4 Hz, 1H), 5.76 (dd, J = 12.9 and 7.8 Hz, 1H), 5.14
(dd, J = 12.7 and 8.4 Hz, 1H), 4.83 (pseudo q, J = 7.8 Hz, 1H).
13C NMR (DMSO-d6): δ 160.7 (s), 147.9 (d), 135.7 (d), 135.6
(s), 130.1 (d), 130.0 (d), 128.6 (s), 118.9 (d), 118.6 (d), 80.0
(d), 59.45 (t), 45.6 (d). Anal. Calcd for C12H11Br2NO: C,
41.77; H, 3.21; N, 4.06. Found: C, 42.22; H, 2.95; N, 4.01.
(1aRS,9aSR,9bSR)-1a,2,8,9,9a,9b-Hexahydrobenzo[e]-
oxireno[a] indol iz ine (6 ) and (1aRS,9aRS,9bSR)-
1a,2,8,9,9a,9b-Hexahydrobenzo[e]oxireno[a]indolizine (7).
Compound 2 (0.345 g, 1.0 mmol) was added to a suspension
of PtO2·H2O (0.023 g, 0.1 mmol) in MeOH (16 mL), and the
mixture was stirred at room temperature under an atmospheric
pressure of hydrogen for 12 h. The solution was filtered
through a celite pad, washed with MeOH and CH2Cl2, and
evaporated to dryness affording a mixture of 4 and 5 as the
major compounds, which was dissolved in THF (12 mL) and
water (4 mL), added with solid KOH (0.168 g, 3.0 mmol), and
heated at 40 °C for 24 h. The reaction crude was extracted with
ethyl acetate (4 × 10 mL), and the resulting organic phase was
dried over anhydrous Na2SO4 and evaporated under reduced
pressure. Chromatographic resolution with CH2Cl2 as the
eluent allowed to isolate compound 7 (Rf = 0.59, 0.030 g,
16%): mp 58−59 °C (ivory crystals from pentane/Et2O). IR,
νmax (KBr): 3040, 2928, 2892, 2841, 1603, 1503, 1459 cm
−1. 1H
NMR (CDCl3): δ 7.05 (t, J = 7.7 Hz, 1H), 6.97 (d, J = 7.4 Hz,
1H), 6.58 (td, J = 7.5, 1.0 Hz, 1H), 6.34 (d, J = 8.1 Hz, 1H),
3.74 (dd, J = 3.2, 1.3 Hz, 1H), 3.72 (ddd, J = 3.2, 1.2, 0.3 Hz,
1H), 3.66 (ddd, J = 11.3, 2.9, 1.2 Hz, 1H), 3.63 (d, J = 11.5 Hz,
1H), 3.34 (dd, J = 11.5, 1.2 Hz, 1H), 2.94−2.78 (m, 2H), 2.10
(ddt, J = 12.5, 5.3, 2.7 Hz, 1H), 1.77 (m, 1H). 13C NMR
(CDCl3): δ 144.3 (s), 128.6 (d), 127.1 (d), 120.5 (s), 115.6
(d), 110.0 (d), 58.5 (d), 57.2 (d), 54.5 (d), 48.9 (t), 27.3 (t),
21.9 (t). HRMS (ESI) m/z: calcd for C12H14NO [MH]
+,
188.1070; found, 188.1074.
The slowest moving fraction afforded oxirane 6 (Rf = 0.27,
0.044 g, 23%) that was crystallized from pentane/Et2O in ivory
flakes: mp 63−64 °C. IR, νmax (KBr): 3034, 2929, 2847, 1602,
1494, 1455 cm−1. 1H NMR (CDCl3): δ 7.08 (t, J = 7.6 Hz,
1H), 7.00 (d, J = 7.4 Hz, 1H), 6.67 (td, J = 7.4, 0.8 Hz, 1H),
6.60 (d, J = 8.1 Hz, 1H), 3.96 (d, J = 11.4 Hz, 1H), 3.85 (dd, J
= 2.9, 2.0 Hz, 1H), 3.71 (d, J = 3.1 Hz, 1H), 3.67 (dd, J = 12.6,
2.4 Hz, 1H), 3.26 (dd, J = 11.3, 1.8 Hz, 1H), 2.93−2.78 (m,
2H), 1.97 (ddt, J = 12.2, 5.0, 2.5 Hz, 1H), 1.39 (qd, J = 12.4, 5.5
Hz, 1H). 13C NMR (CDCl3): δ 145.2 (s), 129.1 (d), 127.0 (d),
122.2 (s), 117.4 (d), 114.8 (d), 60.3 (d), 58.8 (d), 56.7 (d),
Figure 5. Benzo[e]indolizidine derivatives.
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52.1 (t), 27.9 (t), 21.9 (t). HRMS (ESI) m/z: calcd for
C12H14NO [MH]
+, 188.1070; found, 188.1069.
Ring Openings of Oxiranes 6 and 7: General
Procedure. A solution of oxirane (0.094 g, 0.5 mmol) in the
reported solvent (10 mL) was added with H2SO4 and heated at
the reported temperature for the reported time in a screw-cap
tube (Pyrex N. 22) under magnetic stirring. The resulting
mixture was made basic by the addition of NH4OH 30% (ca.
0.5 mL), evaporated to dryness under reduced pressure, and
resolved by FC.
(2SR,3SR,3aSR)-1,2,3,3a,4,5-Hexahydropyrrolo[1,2-a]-
quinoline-2,3-diol (8) and (2RS,3RS,3aSR)-1,2,3,3a,4,5-
Hexahydropyrrolo[1,2-a]quinoline-2,3-diol (9).
(A) Oxirane 6 and aqueous H2SO4 (1 M, 1.25 mL, 1.25
mmol) were heated in THF at 100 °C for 24 h.
Chromatographic resolution (toluene/MeOH/AcOH
7:2:0.15 v/v) allowed to isolate a 3:1 mixture of 8 and
9 (Rf = 0.42, 0.036 g, 35%).
(B) Operating as above with oxirane 7, a 1:4 mixture of 8 and
9 (Rf = 0.42, 0.066 g, 64%) was isolated.
(C) Operating in water as the solvent, a 1:3.5 mixture of 8
and 9 (Rf = 0.42, 0.074 g, 72%) was recovered by heating
oxirane 7 at 40 °C for 60 h. A small amount of pure diol
9 was isolated by FC as a sticky solid. IR, νmax (KBr):
3386, 3043, 2931, 2849, 1604, 1505 cm−1. 1H NMR
(CDCl3): δ 7.07 (t, J = 7.4 Hz, 1H), 7.00 (d, J = 7.4 Hz,
1H), 6.60 (t, J = 7.4 Hz, 1H), 6.41 (d, J = 7.8 Hz, 1H),
4.33 (d, J = 4.8 Hz, 1H), 4.05 (d, J = 3.0 Hz, 1H), 3.79
(dt, J = 11.8, 3.3 Hz, 1H), 3.65 (dd, J = 11.1, 4.8 Hz,
1H), 3.18 (d, J = 11.1 Hz, 1H), 2.99−2.80 (m, 2H),
2.03−1.97 (m, 1H), 1.95−1.51 (vbr s, 2H), 1.79 (pseudo
qd, J = 12.3, 4.8 Hz, 1H). 13C NMR (CDCl3): δ 144.4
(s), 128.5 (d), 127.3 (d), 121.3 (s), 115.8 (d), 110.1 (d),
77.5 (d), 75.2 (d), 59.1 (d), 53.5 (t), 27.5 (t), 20.3 (t).
HRMS (ESI) m/z: calcd for C12H16NO2 [MH]
+,
206.1176; found, 206.1177.
(2SR,3SR,3aSR)-2-Methoxy-1,2,3,3a,4,5-hexahydropyrrolo-
[1,2-a]quinolin-3-ol (10) and (2RS,3RS,3aSR)-3-Methoxy-
1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolin-2-ol (11). Con-
centrated H2SO4 (0.069 mL, 1.25 mmol) was added to a
solution of 6 in dry MeOH (6 mL). After heating at 60 °C for
40 h, the reaction mixture was subjected to chromatographic
separation, with CH2Cl2/EtOAc 5:1 v/v as the eluent. The first
moving band gave a 4:1 mixture (1H NMR) of methoxy
derivatives 10 and 11 (Rf = 0.39, 0.060 g, 55%).
1H NMR
(CDCl3): δ 7.12−7.02 (m, 2H), 7.01−6.96 (m, 2H), 6.62 (td, J
= 7.4, 0.8 Hz, 1H), [6.57 (t, J = 7.3 Hz, 1H)], [6.38 (d, J = 7.9
Hz, 1H)], 6.37 (d, J = 8.0 Hz, 1H), [4.42 (d, J = 4.6 Hz, 1H)],
3.97 (pseudo q, J = 6.7 Hz, 1H), 3.86 (dd, J = 8.3, 7.0 Hz, 1H),
[3.82 (dt, J = 11.7, 3.6 Hz, 1H)], 3.68−3.61 (m, 2H, 10 and
11), [3.54 (dd, J = 10.9, 4.6 Hz, 1H)], 3.50 (s, 3H), [3.43 (s,
3H)], 3.30 (ddd, J = 11.4, 8.4, 3.1 Hz, 1H), [3.22 (d, J = 10.9
Hz, 1H)], 3.17 (dd, J = 9.6, 6.4 Hz, 1H), 2.95−2.75 (m, 4H),
2.61 (br s, 2H), 2.33−2.23 (m, 1H), [1.99−1.90 (m, 1H)],
[1.82 (pseudo qd, J = 12.6, 4.9 Hz, 1H)], 1.58 (pseudo qd, J =
11.8, 6.0 Hz, 1H).h 13C NMR (CDCl3): δ [144.5 (s)], 143.9
(s), 128.7 (d), [128.3 (d)], 127.2 (d), [127.1 (d)], [121.5 (s)],
121.3 (s), 116.2 (d), [115.3 (d)], [109.9 (d)], 109.7 (d), [86.3
(d)], 84.5 (d), 80.6 (d), [72.0 (d)], 61.0 (d), [59.3 (d)], 58.2
(q), [58.1 (q)], [54.0 (t)], 49.6 (t), [27.8 (t)], 27.2 (t), 25.3
(t), [20.3 (t)].h
The following band afforded compound 10 (Rf = 0.29, 0.029
g, 26%) that was crystallized from Et2O/pentane in pale yellow
pearls: mp 109−110 °C. IR, νmax (KBr): 3427, 3038, 2926,
2849, 1601, 1502 cm−1. 1H NMR (CDCl3): δ 7.08 (t, J = 7.5
Hz, 1H), 6.99 (d, J = 7.3 Hz, 1H), 6.61 (td, J = 7.4, 1.0 Hz,
1H), 6.37 (d, J = 7.8 Hz, 1H), 3.97 (pseudo q, J = 7.0 Hz, 1H),
3.86 (t, J = 7.4 Hz, 1H), 3.65 (dd, J = 9.6, 7.7 Hz, 1H), 3.50 (s,
3H), 3.30 (ddd, J = 11.3, 8.0, 3.1 Hz, 1H), 3.17 (dd, J = 9.6, 6.4
Hz, 1H), 2.90−2.76 (m, 2H), 2.33−2.25 (m, 1H), 1.64−1.52
(m, 2H). 13C NMR (CDCl3): δ 143.9 (s), 128.7 (d), 127.2 (d),
121.3 (s), 116.0 (d), 109.7 (d), 84.7 (d), 80.7 (d), 61.0 (d),
58.1 (q), 49.6 (t), 27.2 (t), 25.3 (t).
HRMS (ESI) m/z: calcd for C13H18NO2 [MH]
+, 220.1332;
found, 220.1334.
The slowest moving fraction gave diols 8 and 9 (Rf = 0.04,
0.013 g, 13%) in 1.5:1 ratio (1H NMR).
(2SR,3SR,3aRS)-2-Methoxy-1,2,3,3a,4,5-hexahydropyrrolo-
[1,2-a]quinolin-3-ol (12) and (2RS,3RS,3aRS)-3-Methoxy-
1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolin-2-ol (13). Op-
erating as above on oxirane 7, the reaction mixture was heated
at 40 °C for 24 h and then resolved by FC (CH2Cl2/EtOAc 7:1
v/v). The first band afforded compound 12 (Rf = 0.44, 0.054 g,
49%) as an orange sticky product. IR, νmax (KBr): 3422, 3039,
2930, 2849, 1604, 1502 cm−1. 1H NMR (CDCl3): δ 7.07 (t, J =
7.6 Hz, 1H), 6.99 (d, J = 7.4 Hz, 1H), 6.59 (td, J = 7.6, 1.0 Hz,
1H), 6.41 (d, J = 8.0 Hz, 1H), 4.15 (d, J = 3.0 Hz, 1H), 3.85 (d,
J = 5.1 Hz, 1H), 3.65 (dt, J = 11.8, 3.2 Hz, 1H), 3.58 (dd, J =
11.0, 5.2 Hz, 1H), 3.42 (s, 3H), 3.21 (d, J = 11.0 Hz, 1H),
2.99−2.79 (m, 2H), 2.03−1.96 (m, 1H), 1.81−1.68 (m, 2H).
13C NMR (CDCl3): δ 144.6 (s), 128.4 (d), 127.2 (d), 121.3
(s), 115.7 (d), 110.0 (d), 84.2 (d), 74.7 (d), 59.4 (d), 57.0 (q),
50.5 (t), 27.4 (t), 20.5 (t). HRMS (ESI) m/z: calcd for
C13H18NO2 [MH]
+, 220.1332; found, 220.1335.
The following band gave a mixture of methoxy derivatives 12
and 13 (Rf = 0.34, 0.030 g, 27%) in about 2:1 ratio (
1H NMR).
1H NMR (CDCl3): δ 7.11−7.03 (m, 2H), 6.99 (d, J = 7.3 Hz,
2H), 6.65−6.56 (m, 2H), 6.42 (d, J = 8.0 Hz, 1H), [6.38 (d, J =
8.1 Hz, 1H)], [4.39 (dt, J = 7.4, 5.7 Hz, 1H)], 4.15 (d, J = 2.6
Hz, 1H), 3.86 (d, J = 5.2 Hz, 1H), 3.66 (dt, J = 11.8, 3.1 Hz,
1H), 3.61−3.55 (m, 3H, 12 and 13), [3.58 (s, 3H)], 3.42 (s,
3H), [3.27 (ddd, J = 11.0, 7.6, 3.0 Hz, 1H)], 3.22−3.17 (m,
2H), 3.00−2.77 (m, 4H), [2.34−2.28 (m, 1H)], 2.04−1.95 (m,
1H), 1.84 (br s, 2H), 1.82−1.61 (m, 2H, 12 and 13).i 13C
NMR (CDCl3): δ 144.6 (s), [144.1 (s)], [128.7 (d)], 128.5
(d), 127.2 (d), [127.1 (d)], [121.4 (s)], 121.3 (s), [116.2 (d)],
115.7 (d), [110.2 (d)], 110.1 (d), [91.3 (d)], 84.2 (d),[75.0
(d)], 74.7 (d), [60.9 (d)], 59.4 (d), [58.8 (q)], 57.1 (q), [52.4
(t)], 50.5 (t), 27.4 (t), [27.3 (t)], [26.3 (t)], 20.6 (t).i
The slowest moving fractions afforded diols 8 and 9 (Rf =
0.04, 0.009 g, 9%) in 1:1.5 ratio (1H NMR).
(2SR,3SR,3aSR)-3-Hydroxy-1,2,3,3a,4,5-hexahydropyrrolo-
[1,2-a]quinolin-2-yl Acetate (14a), (2SR,3SR,3aSR)-2-Hy-
droxy-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinolin-3-yl Ac-
e ta te (14b ) , and (2SR ,3SR ,3aSR) -1 ,2 ,3 ,3a ,4 ,5 -
Hexahydropyrrolo[1,2-a]quinoline-2,3-diyl Diacetate (15). A
solution of oxirane 6 and concentrated H2SO4 (0.138 mL, 2.5
mmol) in glacial AcOH was heated at 60 °C for 7 h. Basic
workup by addition of NH4OH 30% (ca. 20 mL), extraction
with EtOAc (4 × 10 mL), and evaporation to dryness of the
organic phase dried over anhydrous Na2SO4 led to a residue
that was resolved by FC with PE/EtOAc 4:1 v/v as the eluent.
The first band gave compound 15 (Rf = 0.61, 0.087 g, 60%)
that was crystallized from pentane/Et2O in white needles: mp
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71−72 °C. IR, νmax (KBr): 3041, 2943, 2847, 1744, 1601, 1501,
1366, 1238 cm−1. 1H NMR (CDCl3): δ 7.08 (t, J = 7.8 Hz,
1H), 7.00 (d, J = 7.4 Hz, 1H), 6.66 (td, J = 7.4, 1.0 Hz, 1H),
6.40 (d, J = 7.5 Hz, 1H), 5.31 (ddd, J = 7.3, 5.2, 4.2 Hz, 1H),
5.16 (dd, J = 7.3, 5.2 Hz, 1H), 3.71 (dd, J = 10.8, 7.3 Hz, 1H),
3.37 (dd, J = 10.7, 4.2 Hz, 1H), 3.35 (ddd, J = 11.3, 7.3, 2.9 Hz,
1H), 2.92−2.70 (m, 2H), 2.27−2.19 (m, 1H), 2.13 (s, 3H),
2.09 (s, 3H), 1.82−1.70 (m, 1H). 13C NMR (CDCl3): δ 170.7
(s), 170.3 (s), 143.7 (s), 128.9 (d), 127.1 (d), 121.5 (s), 117.0
(d), 110.8 (d), 79.9 (d), 75.6 (d), 60.3 (d), 51.0 (t), 26.7 (t),
25.3 (t), 20.95 (q), 20.9 (q). Anal. Calcd for C16H19NO4: C,
66.42; H, 6.62; N, 4.84. Found: C, 66.04; H, 6.89; N, 4.51.
The following band afforded an almost 1:1 mixture of
monoacetates 14a,b (Rf = 0.20, 0.017 g, 14%).
1H NMR
(CDCl3): δ 7.11−7.06 (m, 2H), 7.03−6.97 (m, 2H), 6.67−6.61
(m, 2H), 6.44−6.36 (m, 2H), 5.05 (ddd, J = 8.2, 5.4, 4.8 Hz,,
1H, 14a), 4.64 (dd, J = 8.2, 5.5 Hz, 1H, 14b), 4.44−4.39 (m,
1H, 14b), 3.90 (dd, J = 8.2, 5.6 Hz, 1H, 14a), 3.66−3.59 (m,
2H), 3.46−3.35 (m, 3H, 14b and 14a), 3.28 (ddd, J = 11.1, 8.2,
2.9 Hz, 1H, 14a), 2.95−2.76 (m, 4H), 2.40−2.32 (m, 1H, 14a),
2.27−2.21 (m, 1H, 14b), 2.17 (s, 3H, 14b), 2.15 (s, 3H, 14a),
1.77−1.62 (m, 4H). 13C NMR (CDCl3): δ 173.0 (s, 14a),
172.8 (s, 14b), 143.9 (s, 14a), 143.8 (s, 14b), 128.8 (d, 14b),
128.7 (d, 14a), 127.2 (d, 14b), 127.1 (d, 14a), 121.8 (s, 14a),
121.4 (s, 14b), 116.9 (d, 14a), 116.8 (d, 14b), 110.6 (d, 14b),
110.4 (d, 14a), 86.2 (d, 14a), 81.1 (d, 14b), 80.8 (d, 14b), 74.8
(d, 14a), 61.7 (d, 14a), 59.9 (d, 14b), 52.7 (t, 14b), 50.0 (t,
14a), 27.0 (t, 2x), 25.6 (t, 14a), 25.5 (t, 14a), 20.9 (q, 2x).
The slowest moving band led to diol 8 (Rf = 0.08, 0.008 g,
8%).
Reaction of Oxirane 7 with AcOH/H2SO4: Synthesis of
(2SR,3SR,3aSR)-1,2,3,3a,4,5-Hexahydropyrrolo[1,2-a]-
quinoline-2,3-diyl Diacetate (15) and (2SR,3SR,3aRS)-
1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinoline-2,3-diyl Diac-
etate (17). Operating as above, chromatographic resolution
(PE/EtOAc 4:1 v/v) of the reaction mixture obtained from
oxirane 7 after heating for 36 h led to a 1:3.5 mixture of
diacetates 15 and 17 (Rf = 0.61, 0.043 g, 30%).
1H NMR
(CDCl3): δ 7.13−7.05 (m, 2H), 7.01 (d, J = 7.3 Hz, 2H), [6.66
(td, J = 7.4, 1.0 Hz, 1H)], 6.61 (td, J = 7.4, 0.9 Hz, 1H), 6.42−
6.36 (m, 2H), [5.34−5.28 (m, 1H)], 5.32 (d, J = 3.5 Hz, 1H),
5.24 (d, J = 5.1 Hz, 1H), [5.16 (dd, J = 7.3, 5.2 Hz, 1H)], 3.89
(dt, J = 11.6, 3.4 Hz, 1H), [3.75−3.66 (m, 1H)], 3.70 (dd, J =
11.5, 5.1 Hz, 1H), [3.41−3.32 (m, 2H)], 3.32 (d, J = 11.5 Hz,
1H), 2.97−2.76 (m, 4H), [2.26−2.18 (m, 1H)], [2.13 (s, 3H)],
2.10 (s, 3H), [2.09 (s, 3H)], 2.06 (s, 3H), 2.02−1.94 (m, 1H),
[1.82−1.70 (m, 1H)], 1.65−1.53 (m, 1H).j 13C NMR
(CDCl3): δ [170.8 (s)], [170.7 (s)], 169.9 (s, 2x), [143.7
(s)], 143.6 (s), [128.9 (d)], 128.5 (d), 127.4 (d), [127.1 (d)],
[121.5 (s)], 121.0 (s), [117.0 (d)], 115.9 (d), [110.8 (d)],
109.9 (d), [79.8 (d)], 76.2 (d), [75.6 (d)], 74.8 (d), [60.3 (d)],
59.0 (d), 51.5 (t), [51.0 (t)], 27.3 (t), [27.0 (t)], [25.3 (t)],
21.0 (q), [20.9 (q, 2x)] (q), 20.6 (t).j
The following band afforded an almost 1:5 mixture of a
couple of monoacetates 14a,b and 16a,b (Rf = 0.20, 0.035 g,
28%).
The slowest moving band led to a 1:2 mixture of diols 8 and
9 (Rf = 0.08, 0.008 g, 8%).
(2SR,3SR,3aSR)-1,2,3,3a,4,5-Hexahydropyrrolo[1,2-a]-
quinoline-2,3-diol (8). A solution of oxirane 6 and concen-
trated H2SO4 (0.138 mL, 2.5 mmol) in glacial AcOH was
heated at 60 °C for 7 h. Then, water (10 mL) was added, and
the resulting mixture was heated at the same temperature for 60
h. Basic workup by addition of NH4OH 30% (ca. 20 mL),
extraction with EtOAc (4 × 10 mL), and evaporation to
dryness of the dried organic phase gave a residue that was
subjected to FC, with CH2Cl2/MeOH 9.5:0.5 v/v as the eluent.
Compound 8 (Rf = 0.37, 0.084 g, 82%) was recovered and
crystallized from Et2O in ivory crystals: mp 150−151 °C. IR,
νmax (KBr): 3360, 3304, 3212, 3074, 2957, 2916, 2839, 1602,
1505 cm−1. 1H NMR (CDCl3): δ 7.07 (t, J = 7.7 Hz, 1H), 6.99
(d, J = 7.4 Hz, 1H), 6.61 (td, J = 7.4, 1.0 Hz, 1H), 6.36 (d, J =
7.8 Hz, 1H), 4.37 (pseudo q, J = 7.3 Hz, 1H), 3.79 (dd, J = 8.1,
7.3 Hz, 1H), 3.68 (dd, J = 9.6, 7.9 Hz, 1H), 3.32 (ddd, J = 11.4,
8.3, 3.2 Hz, 1H), 3.14 (dd, J = 9.7, 7.0 Hz, 1H), 2.89−2.74 (m,
2H), 2.49 (br s, 2H), 2.32−2.25 (m, 1H), 1.57 (pseudo qd, J =
11.4, 6.4 Hz, 1H). 13C NMR (CDCl3): δ 143.6 (s), 128.7 (d),
127.3 (d), 121.3 (s), 116.1 (d), 109.7 (d), 82.2 (d), 76.1 (d),
61.2 (d), 51.4 (t), 27.2 (t), 25.2 (t). Anal. Calcd for
C12H15NO2: C, 70.22; H, 7.37; N, 6.82. Found: C, 69.83; H,
7.73; N, 6.60.
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■ ADDITIONAL NOTES
aThe conversion was almost instantaneous in dimethyl
sulfoxide (DMSO), but the use of water was preferred, being
a green solvent and allowing an easier recovery of the product.
bMinor amounts of fully reduced products were also observed
via 1H NMR analyses.
cLikely, the presence of an aniline moiety in the reduction
products is responsible for decomposition/polymerization
processes.
d1H NMR analyses of the reaction crudes with D2O as the
solvent, for both epoxides, clearly evidenced the total
deuteration at positions 5 and 7, likely an aromatic electrophilic
substitution activated by the aniline-type ring nitrogen in diols
8 and 9.
eThe reaction was performed with a 1:5 molar ratio epoxide/
H2SO4 to favor the formation of diacetate 15 (see Experimental
Section).
fThe spectrum of the diastereomeric mixture has been recorded
in CD3OD because in DMSO-d6, the cis salt immediately
isomerizes into the trans one.
gThe data reported in square brackets refer to the trans
indolizinium bromide 2.
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hThe data reported in square brackets refer to compound 11.
iThe data reported in square brackets refer to compound 13.
jThe data reported in square brackets refer to compound 15.
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